Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline in Neonates and Young Infants with Late-Onset Sepsis
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Sepsis
- Focus Adverse reactions
- Sponsors AstraZeneca; Pfizer
- 06 Oct 2016 This trial is completed in Spain, according to Eudra record.
- 11 Aug 2016 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
- 11 Aug 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2017.